Veracyte, Inc.

VCYT
Real-time BATS EXCHANGE - 01/21 04:58:16 pm
28.495USD
-5.97%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Diagnostics & Testing
Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier and Afirma Xpression Atlas. It provides GSC tests for thyroid cancer. It provides Percepta Bronchial Genomic Classifier tests for lung cancer. It provides Envisia Genomic Classifier tests for idiopathic pulmonary fibrosis (IPF). Its Afirma Xpression Atlas provides information on gene alterations associated with thyroid cancer, enabling physicians to tailor surgical and treatment decisions at time of diagnosis.

Number of employees : 270 people.
Sales per Businesses
20172018
USD
(in Million)
%USD
(in Million)
%
Genomic Diagnostics 71.95100% 92.01100%
Sales per Regions
20172018
USD
(in Million)
%USD
(in Million)
%
United States 71.95100% 92.01100%
Managers
Name Title
Bonnie H. Anderson Chairman & Chief Executive Officer
Keith Kennedy Chief Operating & Financial Officer
Giulia C. Kennedy Chief Scientific & Medical Officer
Ashish Kheterpal Chief Information Officer
Fred E. Cohen Independent Director
Evan Jones Independent Director
Karin Eastham Independent Director
John L. Bishop Lead Independent Director
Robert S. Epstein Independent Director
Tina Susan Nova Independent Director
Shareholders
Name Equities %
Gilder, Gagnon, Howe & Co. LLC 3,824,626 7.83%
Invesco Advisers, Inc. 2,977,145 6.10%
Nikko Asset Management Americas, Inc. 2,764,236 5.66%
Nikko Asset Management Co., Ltd. 2,764,236 5.66%
ARK Investment Management LLC 2,582,798 5.29%
The Vanguard Group, Inc. 2,447,067 5.01%
Versant Venture Management LLC 2,410,814 4.94%
SSgA Funds Management, Inc. 2,115,754 4.33%
BlackRock Fund Advisors 1,567,362 3.21%
Wellington Management Co. LLP 1,047,487 2.14%
Company contact information
Veracyte, Inc.
6000 Shoreline Court
Suite 300
South San Francisco, CA 94080

Phone : +1.650.243.6300
Fax : +1.650.243.6301
Web : http://www.veracyte.com
Sector Bio Diagnostics & Testing
1st jan.Capi. (M$)
VERACYTE, INC.1.76%1 473
GUARDANT HEALTH, INC.8.27%7 944
GENSCRIPT BIOTECH CORPORATION2.60%4 536
IOVANCE BIOTHERAPEUTICS, INC.-14.49%3 013
INVITAE CORPORATION21.70%1 895
MIRACA HOLDINGS INC.1.24%1 414
CAREDX, INC9.46%1 002
SEEGENE INC--.--%704
INNATE PHARMA14.60%606
EPIGENOMICS AG3.30%67
LYSOGENE147.93%56